Age, sex, SLE features or treatment and history of infection including viral infection rates or types did not differ between SLE patients with or without anti-IFNα, except for tuberculosis disease which was more frequent in patients with anti-IFNα (20% vs 3.1%, p = 0.01) (Table 1). The gene discussed is IFNA17; the disease is infection.